363 related articles for article (PubMed ID: 24245986)
1. Differences in incidence and trends of haematological malignancies in Japan and the United States.
Chihara D; Ito H; Matsuda T; Shibata A; Katsumi A; Nakamura S; Tomotaka S; Morton LM; Weisenburger DD; Matsuo K
Br J Haematol; 2014 Feb; 164(4):536-45. PubMed ID: 24245986
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of the incidence and trends of hematologic malignancies between Japan and the United States].
Chihara D; Ito H; Matsuo K
Rinsho Ketsueki; 2015 Apr; 56(4):366-74. PubMed ID: 25971266
[TBL] [Abstract][Full Text] [Related]
3. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
4. Family history of hematopoietic malignancy and risk of lymphoma.
Chang ET; Smedby KE; Hjalgrim H; Porwit-MacDonald A; Roos G; Glimelius B; Adami HO
J Natl Cancer Inst; 2005 Oct; 97(19):1466-74. PubMed ID: 16204696
[TBL] [Abstract][Full Text] [Related]
5. Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012.
Ko BS; Chen LJ; Huang HH; Wen YC; Liao CY; Chen HM; Hsiao FY
Cancer Med; 2018 Nov; 7(11):5820-5831. PubMed ID: 30460792
[TBL] [Abstract][Full Text] [Related]
6. [Incidence of haematological malignancies in adults in Szabolcs-Szatmár-Bereg county, Hungary, between 1983 and 2012. Analysis of data from a thirty-year period].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2013 Nov; 154(47):1858-64. PubMed ID: 24240522
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
8. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
Tadmor T; Liphshitz I; Silverman B; Polliack A
Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
[TBL] [Abstract][Full Text] [Related]
9. Familial aggregation of early-onset haematological malignancies.
Rönkkö R; Hirvonen E; Malila N; Kilpivaara O; Wartiovaara-Kautto U; Pitkäniemi J
Br J Haematol; 2021 Jun; 193(6):1134-1141. PubMed ID: 34002362
[TBL] [Abstract][Full Text] [Related]
10. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
11. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology of haematological cancers in Sarawak, Malaysia (1996 to 2015).
Kuan JW; Su AT; Wahab M; Hamdan A; Hashim J; Kiyu A; Ooi CH
BMC Cancer; 2023 Jun; 23(1):563. PubMed ID: 37337159
[TBL] [Abstract][Full Text] [Related]
13. Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA.
Georgakis MK; Karalexi MA; Agius D; Antunes L; Bastos J; Coza D; Demetriou A; Dimitrova N; Eser S; Florea M; Ryzhov A; Sekerija M; Žagar T; Zborovskaya A; Zivkovic S; Bouka E; Kanavidis P; Dana H; Hatzipantelis E; Kourti M; Moschovi M; Polychronopoulou S; Stiakaki E; Kantzanou Μ; Pourtsidis A; Petridou ET
Cancer Causes Control; 2016 Nov; 27(11):1381-1394. PubMed ID: 27757777
[TBL] [Abstract][Full Text] [Related]
14. Wage-subsidised employment as a result of permanently reduced work capacity in a nationwide cohort of patients diagnosed with haematological malignancies.
Horsboel TA; Nielsen CV; Nielsen B; Andersen NT; De Thurah A
Acta Oncol; 2015 May; 54(5):743-9. PubMed ID: 25752974
[TBL] [Abstract][Full Text] [Related]
15. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
16. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
17. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
Pulte D; Gondos A; Brenner H
J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
[TBL] [Abstract][Full Text] [Related]
18. Long-term time trends in incidence, survival and mortality of lymphomas by subtype among adults in Manitoba, Canada: a population-based study using cancer registry data.
Ye X; Mahmud S; Skrabek P; Lix L; Johnston JB
BMJ Open; 2017 Jul; 7(7):e015106. PubMed ID: 28716788
[TBL] [Abstract][Full Text] [Related]
19. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients.
Pehalova L; Krejci D; Halamkova J; Smardova L; Snajdrova L; Dusek L
Cancer Epidemiol; 2021 Jun; 72():101929. PubMed ID: 33819838
[TBL] [Abstract][Full Text] [Related]
20. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
